C4 Therapeutics
CCCC
$6.74
Share price
4.82%
Change (1 day)
114.65%
Change (1 year)
Categories
EPS for C4 Therapeutics (CCCC)
EPS in 2023 (TTM): -$2.75
According to C4 Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.75. In 2022 the company made an earnings per share (EPS) of -$2.62 a decrease over its 2021 EPS that were of -$1.82.
EPS history for C4 Therapeutics from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.75 | 4.96% |
| 2022 | -$2.62 | 43.96% |
| 2021 | -$1.82 | -12.45% |
| 2020 | -$2.08 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -20.73% | 🇺🇸 USA |